Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Meningeal Carcinomatosis 7Breast Neoplasms 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Astrocytoma 3Neoplastic Cells, Circulating 2Glioma 2Brain Neoplasms 2Oligodendroglioma 1Neoplasm Recurrence, Local 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma, Follicular 1

Interventions

Radiotherapy 6Temozolomide 5Flow Cytometry 5Cyclophosphamide 5Therapeutics 4Psychiatric Rehabilitation 4Melphalan 4Magnetic Resonance Spectroscopy 4Filgrastim 4sargramostim 3Specimen Handling 3Polymerase Chain Reaction 3Methylprednisolone 3liposomal amphotericin B 2Topotecan 2Thiotepa 2Rituximab 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Fentanyl 2Early Intervention, Educational 2Dexamethasone 2Caspofungin 2Carmustine 2Calcium Dobesilate 2Busulfan 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Spinal Puncture × CNS × Clear all
NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting
33 enrolled
CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡